Home
Science and IP
Investors
Our Team
Events
News Releases
Contact
NASDAQ: CMND
FWB: CWY0
News Releases
Below are the latest News Releases for Clearmind Medicine Inc.
16
December
2025
Clearmind Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
Read More
12
December
2025
Clearmind's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for AUD Treatment
Read More
10
December
2025
Clearmind Medicine Announces 1-for-40 Reverse Share Split
Read More
2
December
2025
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial
Read More
25
November
2025
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center
Read More
24
November
2025
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100
Read More
20
November
2025
Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site
Read More
18
November
2025
Clearmind Announces Positive Top-Line Results from 1st Cohort of FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Read More
17
November
2025
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
Read More
13
November
2025
Clearmind Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for AUD at Hadassah Medical Center
Read More
12
November
2025
Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment
Read More
5
November
2025
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing
Read More
31
October
2025
Clearmind Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application
Read More
30
October
2025
Clearmind Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Read More
28
October
2025
Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at Women in Psychedelic Leadership Webinar
Read More
Next
